present
previous
evid
cytopathogen
strain
hepat
viru
hav
induc
degrad
ribosom
rna
rrna
infect
cell
arch
virol
contrast
noncytopathogen
parent
viru
clone
effect
rrna
integr
present
data
show
rrna
degrad
follow
apoptosi
accompani
characterist
dna
ladder
cytoplasm
infect
cell
dna
ladder
coincid
detect
caspas
cleavag
depend
upon
activ
caspas
pathway
sinc
treatment
zvadfmk
pancaspas
inhibitor
inhibit
event
rnase
l
mrna
present
virusinfect
uninfect
cell
messeng
rna
interferon
induc
enzym
oligoadenyl
synthetas
oa
polymer
atp
oligo
adenyl
activ
rnase
l
presenc
doublestrand
rna
detect
follow
viru
infect
oa
mrna
induc
treatment
cell
mrna
margin
induc
follow
infect
howev
phosphoryl
stat
key
regul
interferonstimul
gene
transcript
detect
viru
infect
cell
stat
phosphoryl
respons
ifn
treatment
lower
virusinfect
cell
compar
uninfect
cell
treat
interferon
suggest
viru
infect
interfer
interferon
signal
result
suggest
infect
caus
induct
independ
rnase
l
like
activ
publish
elsevi
bv
hepat
viru
picornaviru
known
member
genu
hepatoviru
major
caus
agent
infecti
hepat
worldwid
easili
dissemin
person
person
contact
well
via
contamin
food
water
due
resist
environment
factor
heat
low
ph
etc
siegl
et
al
gust
known
hav
strain
establish
slowli
replic
noncytopathogen
persist
infect
permiss
cell
vitro
provost
hillemen
flehmig
binn
et
al
vallbracht
et
al
contrast
vivo
infect
persist
restrict
week
lemon
vallbracht
et
al
although
sporad
case
chronic
infect
report
fagan
et
al
inou
et
al
sever
laboratori
isol
rapidli
replic
cytopathogen
cp
strain
produc
visibl
morpholog
chang
primarili
continu
cell
line
monkey
kidney
origin
divizia
et
al
venuti
et
al
anderson
cromean
et
al
nasser
metcalf
zhang
et
al
brack
et
al
mechan
cytopathogen
effect
cpe
produc
rapidli
replic
hav
strain
intens
investig
past
year
understand
wild
type
wt
cell
cultur
adapt
cc
strain
replic
slowli
unabl
induc
cpe
cell
line
studi
reveal
genom
cpeinduc
cp
strain
contain
point
mutat
compar
wt
strain
deriv
scatter
throughout
genom
well
repeat
nontransl
region
ntr
harbor
intern
ribosom
entri
site
ire
lemon
et
al
brack
et
al
biolog
signific
mutat
rapid
replic
phenotyp
cp
strain
complet
understood
experi
chimer
viral
genom
contain
mutat
region
cp
strain
genet
background
cc
strain
suggest
effect
mutat
express
viral
genom
possibl
due
alter
interact
mutat
genom
cellular
protein
either
posit
neg
regul
viral
gene
express
whetter
et
al
zhang
et
al
funkhous
et
al
yi
et
al
howev
view
hav
ire
ineffici
compar
picornavirus
univers
accept
jia
et
al
graff
ehrenfeld
kusov
recent
report
permiss
monkey
kidney
cell
line
infect
cp
strain
hereaft
refer
result
degrad
ribosom
rna
rrna
wherea
viral
genom
rna
degrad
contrast
parent
cc
strain
caus
degrad
either
acut
infect
extend
persist
infect
kulka
et
al
base
pattern
rrna
degrad
intact
ribosom
suggest
viru
activ
interferon
ifn
control
oligoadenyl
aciddepend
rnase
l
pathway
recent
review
see
stark
et
al
barber
sen
sinc
pathway
essenti
antivir
mechan
mount
cell
defens
viral
infect
usurp
pathway
viru
could
mechan
employ
viru
reduc
competit
cellular
mrna
host
protein
synthet
machineri
viru
lack
activ
proteas
schultheiss
et
al
harmon
et
al
capabl
degrad
either
cellular
translat
factor
requir
translat
cap
cellular
mrna
therefor
import
rna
degrad
mechan
overst
activ
rnase
l
pathway
control
ifn
stark
et
al
barber
sen
induct
oligoadenyl
synthetas
oa
synthes
oligoadenyl
acid
proxim
activ
rnase
l
atp
presenc
doubl
strand
rna
dsrna
overexpress
rnase
l
shown
inhibit
growth
divers
rna
virus
zhou
et
al
whether
hav
infect
induc
synthesi
type
ifn
ifn
cultur
cell
intact
organ
consequ
activ
oasrnas
l
pathway
remain
unclear
cell
cultur
persist
infect
cultureadapt
hav
induc
type
ifn
replic
viru
persist
infect
cell
remain
sensit
exogen
ad
ifn
vallbracht
et
al
brack
et
al
acut
infect
cc
cp
strain
hav
caus
induct
ifn
mrna
transcript
cc
strain
also
block
ifn
mrna
transcript
secret
ifn
respons
dsrna
cell
brack
et
al
exogen
ifn
inhibit
viru
replic
ad
either
exposur
viru
dose
depend
manner
cell
cranc
et
al
inhibit
viru
replic
studi
also
show
strong
depend
multipl
infect
moi
signific
increas
activ
ifninduc
oa
observ
follow
ifn
treatment
suggest
rnase
l
pathway
may
involv
inhibit
viru
replic
cranc
et
al
constitut
express
oa
result
inhibit
picornaviru
replic
chebath
et
al
ectop
express
activ
rnase
l
induc
apoptosi
anim
cell
diazguerra
et
al
castelli
et
al
goal
investig
studi
role
ifn
regul
activ
rnase
l
rna
degrad
apoptosi
infect
cell
monkey
kidney
cell
line
kind
gift
dr
g
kaplan
fda
center
biolog
evalu
research
bethesda
md
cell
grown
eagl
minim
essenti
medium
emem
contain
heat
inactiv
fetal
bovin
serum
fb
mem
nonessenti
amino
acid
sodium
pyruv
invitrogen
carlsbad
ca
routin
weekli
subcultur
condit
cell
increas
day
cell
line
contact
inhibit
kept
growth
medium
mainten
medium
fb
sever
week
without
degener
monolay
hav
strain
cytopathogen
cell
noncytopathogen
cell
obtain
atcc
virus
grown
cell
viru
stock
prepar
describ
kulka
et
al
titer
plaqu
assay
clone
viru
titer
eia
plate
describ
previous
goswami
et
al
use
havab
eia
diagnost
kit
abbott
laboratori
abbott
park
il
human
pancaspas
inhibitor
zvadfmk
obtain
sigma
st
loui
mo
confluent
cultur
cell
cm
flask
cell
infect
multipl
infect
moi
pfucel
tcid
cell
clone
ml
mem
contain
heat
inactiv
fb
mock
infect
h
adsorpt
ml
medium
ad
flask
incub
continu
desir
time
harvest
cell
harvest
scrape
centrifug
remov
medium
pellet
wash
pb
ca
mg
free
store
frozen
c
use
immedi
rna
isol
carri
previous
describ
kulka
et
al
persist
infect
cell
clone
viru
establish
describ
kulka
et
al
cell
maintain
routin
subcultur
manner
normal
cell
monitor
viru
replic
cell
period
seed
plate
along
uninfect
cell
viral
antigen
methanol
fix
cell
measur
havab
eia
procedur
goswami
et
al
kulka
et
al
experi
cell
line
hereaft
refer
clone
carri
month
year
routin
subcultur
cell
pellet
uninfect
viru
infect
cell
resuspend
mm
trishcl
mm
edta
ph
lyse
addit
triton
brack
et
al
cell
lysat
kept
ice
min
intermitt
vortex
mix
follow
centrifug
g
min
supernat
care
remov
digest
proteinas
k
mgml
presenc
sd
digest
extract
equal
volum
phenol
chloroform
isoamyl
alcohol
pcia
aqueou
phase
remov
fresh
tube
nucleic
acid
precipit
addit
sodium
acet
volum
ethanol
precipit
collect
centrifug
wash
ethanol
dri
dissolv
rnasednas
free
water
nucleic
acid
quantit
measur
equal
amount
sampl
incub
c
min
l
te
without
u
clone
rnase
ambion
austin
tx
analyz
agaros
gel
electrophoresi
tbe
denatur
agaros
gel
electrophoresi
perform
describ
kulka
et
al
chomczynski
mackey
gel
photograph
uv
light
induct
apoptosi
investig
incorpor
biotin
label
deoxyribonucleotid
detect
biotin
incorpor
accord
manufactur
instruct
deadend
colorimetr
tunel
system
promega
cell
seed
four
well
chamber
slide
infect
confluenc
pfucel
cell
fix
tunel
assay
h
pi
persist
infect
cell
seed
four
well
chamber
slide
process
monolay
reach
confluenc
viral
antigenposit
cell
display
immunohistochemistri
use
antibodi
kulka
et
al
briefli
cell
fix
buffer
formalin
permeabil
tween
pb
react
dilut
rabbit
antibodi
pb
contain
nonfat
dri
milk
nadala
loh
sever
wash
pb
contain
tween
cell
incub
hrp
label
antirabbit
igg
dilut
nonfat
dri
milk
follow
sever
wash
remov
unbound
antibodi
color
develop
use
cndab
substrat
pierc
chemic
co
total
cytoplasm
rna
digest
rnase
free
dnase
promega
presenc
rnasin
rnase
inhibitor
follow
pcia
extract
ethanol
precipit
remov
contamin
dna
rna
sampl
g
revers
transcrib
use
amv
revers
transcriptas
total
volum
l
use
g
oligo
dt
primer
describ
previous
goswami
et
al
mrna
amplifi
use
primer
pair
sens
antisens
anneal
temperatur
c
primer
pair
amplifi
fragment
brack
et
al
amplif
form
oa
carri
primer
sens
antisens
amplifi
fragment
nucleotid
sens
antisens
amplifi
fragment
nucleotid
anneal
c
respect
takahashi
et
al
amplifi
rnase
l
mrna
follow
primer
synthes
base
sequenc
human
rnase
l
genbank
access
number
nm
rnase
l
sens
rnase
l
antisens
amplifi
fragment
nucleotid
anneal
temperatur
c
mrna
level
use
normal
rtpcr
signal
gener
mrna
primer
sens
antisens
anneal
temperatur
c
viral
rna
total
cytoplasm
rna
sampl
amplifi
use
primer
sens
antisens
primer
pair
direct
end
hav
genom
differenti
genom
clone
strain
hav
base
presenc
addit
base
ntr
genom
goswami
et
al
kulka
et
al
pcr
amplif
carri
total
volum
l
contain
l
cdna
pool
mm
mgcl
deoxynucleosid
triphosph
pmol
primer
u
taq
dna
polymeras
promega
cycl
cell
mock
infect
infect
pfucel
tcid
cell
clone
pfucel
coxsackieviru
mem
contain
heat
inactiv
fb
h
adsorpt
period
medium
ad
flask
incub
continu
indic
time
period
infect
cultur
treat
zvadfmk
viru
adsorpt
media
remov
prior
addit
fb
contain
inhibitor
subsequ
incub
h
indic
time
posttreat
cell
cultur
monolay
scrape
media
pellet
centrifug
g
c
cell
extract
prepar
protein
content
estim
describ
previous
kulka
et
al
equal
concentr
protein
extract
adjust
equival
volum
denatur
sampl
buffer
heat
c
min
subject
sdspage
reduc
condit
follow
electrophoret
transfer
onto
nitrocellulos
membran
transfer
buffer
contain
methanol
membran
block
tbst
tri
buffer
tween
contain
nonfat
dri
milk
nfdm
min
room
temperatur
rt
wash
four
time
tbst
membran
incub
either
overnight
c
h
rt
primari
antibodi
dilut
tbst
contain
either
bsa
nfdm
primari
antibodi
use
recogn
phosphoryl
state
independ
phosphoryl
tyrosin
posit
cell
signal
technolog
use
dilut
bsa
incub
overnight
c
ii
full
lengthlarg
cleav
fragment
cell
signal
technolog
use
dilut
nfdm
overnight
incub
c
iii
full
lengthlarg
cleav
fragment
parp
sigma
use
dilut
bsa
h
incub
rt
iv
sigma
use
dilut
nfdm
h
incub
rt
secondari
antibodyhrp
conjug
pierceendogen
use
dilut
step
includ
detect
perform
previous
describ
kulka
et
al
confluent
cultur
cell
plate
infect
pfucel
describ
previous
replic
viru
assess
level
viral
antigen
well
describ
use
havab
eia
kit
goswami
et
al
kulka
et
al
previou
investig
demonstr
cp
strain
hav
deriv
cc
strain
induc
apoptosi
cell
h
postinfect
pi
increas
day
pi
brack
et
al
similar
slowli
develop
cpe
apoptosi
report
cell
infect
anoth
cp
strain
gosert
et
al
contrast
cell
infect
strain
develop
extens
cpe
approxim
cell
h
almost
total
cpe
observ
h
kulka
et
al
use
colorimetr
tunel
assay
h
pi
investig
whether
cpe
induc
strain
result
apoptosi
fig
tunel
posit
cell
present
infect
monolay
wherea
posit
stain
cell
occasion
observ
absenc
viru
infect
persist
infect
clone
cell
day
day
pi
also
show
occasion
posit
stain
cell
cultur
remain
viabl
howev
like
cpe
observ
year
weekli
passag
immunohistochem
stain
perform
persist
infect
clone
cell
determin
persist
infect
statu
cell
due
lack
activ
replic
viru
major
cell
popul
fig
almost
cell
show
posit
stain
viral
antigen
addit
replic
viru
measur
eia
confirm
presenc
activ
replic
viru
data
shown
taken
togeth
result
show
strain
caus
apoptosi
infect
cell
much
earlier
cell
infect
cp
strain
lack
apoptosi
persist
infect
cell
due
lack
activ
viru
replic
previous
shown
rrna
degrad
depend
upon
replic
sinc
treatment
inhibit
replic
also
result
inhibit
rrna
degrad
howev
certain
cell
line
sensit
perturb
cellular
macromolecul
synthesi
driven
apoptot
cell
death
treatment
metabol
inhibitor
instanc
apoptosi
caus
rrna
fragment
houg
et
al
therefor
determin
whether
rrna
degrad
caus
effect
apoptosi
infect
necessari
establish
tempor
sequenc
two
event
cell
infect
total
nucleic
acid
cytoplasm
prepar
differ
time
describ
section
control
cytoplasm
nucleic
acid
also
isol
mock
infect
cell
persist
infect
clone
cell
nucleic
acid
analyz
agaros
gel
electrophoresi
digest
rnase
fig
degrad
molecul
discret
product
fig
rapid
induct
apoptosi
infect
cell
confluent
cultur
cell
mock
infect
infect
cytopath
strain
hav
cell
process
detect
tunel
posit
cell
h
pi
describ
section
persist
infect
cultur
follow
infect
noncytopath
clone
strain
hav
establish
describ
section
cell
process
tunel
posit
cell
day
day
post
infect
evid
h
pi
h
pi
littl
intact
rrna
could
detect
appear
apoptot
dna
ladder
cytoplasm
could
detect
follow
elimin
rrna
total
nucleic
acid
prepar
rnase
clearli
lag
behind
rrna
degrad
result
infect
fig
panel
neither
mock
infect
cell
persist
infect
clone
cell
show
evid
rna
dna
degrad
fig
panel
b
evid
rna
dna
degrad
could
seen
nucleic
acid
prepar
cell
infect
viru
h
pi
data
shown
data
indic
rrna
degrad
infect
cell
occur
prior
apoptosi
consequ
apoptosi
dna
fragment
previou
studi
shown
rrna
degrad
cell
overexpress
ifn
regul
activ
rnase
l
result
apoptosi
due
activ
caspas
rusch
et
al
caspas
termin
enzym
caspas
cascad
activ
caspas
upstream
caspas
occur
due
proteolyt
cleavag
review
see
roulston
et
al
investig
similar
activ
caspas
take
place
due
infect
viru
investig
caspas
activ
western
blot
experi
fig
proteolyt
cleavag
caspas
could
detect
infect
cell
h
pi
coincid
appear
dna
ladder
cytoplasm
compar
fig
panel
fig
panel
proteolysi
caspas
detect
earlier
time
persist
infect
clone
cell
fig
panel
confirm
caspas
activ
follow
rrna
degrad
fig
activ
caspas
accompani
degrad
poli
adpribos
polymeras
target
caspas
apoptot
respons
kaufmann
et
al
cleavag
evid
h
pi
coincid
appear
activ
caspas
parp
longer
detect
infect
cell
h
pi
fig
panel
b
commensur
lack
caspas
activ
rna
degrad
cleavag
parp
persist
infect
cell
shown
proteolyt
activ
caspas
infect
cell
interest
determin
apoptot
dna
degrad
consequ
caspas
activ
cell
infect
treat
differ
concentr
caspas
inhibitor
zvadfmk
h
cultur
process
analysi
caspas
activ
western
blot
describ
section
caspas
activ
prevent
dose
depend
manner
treatment
zvadfmk
fig
signific
inhibit
caspas
activ
achiev
zvadfmk
complet
inhibit
observ
inhibitor
rna
dna
analys
agaros
gel
electrophoresi
cytoplasm
infect
cell
carri
establish
connect
caspas
activ
apoptot
dna
ladder
fig
treatment
infect
cell
zvadfmk
prevent
rrna
degrad
panel
appear
apoptot
dna
ladder
cytoplasm
complet
prevent
panel
b
result
show
rrna
degrad
independ
caspas
induc
dna
degrad
fig
effect
caspas
inhibitor
zvadfmk
proteolyt
activ
caspas
respons
infect
cell
infect
pfucel
incub
growth
medium
contain
inhibitor
h
prior
protein
extract
electrophoresi
transfer
immunodetect
antibodi
caspas
perform
describ
section
lane
mark
contain
protein
extract
mock
infect
cell
harvest
process
h
follow
mock
infect
absenc
inhibitor
fig
effect
zvadfmk
rrna
degrad
apoptot
dna
ladder
cytoplasm
infect
cell
cell
infect
pfucel
mock
infect
incub
growth
medium
contain
zvadfmk
h
prior
isol
total
cytoplasm
nucleic
acid
sampl
separ
agaros
gel
b
digest
rnase
consequ
apoptosi
due
perturb
cellular
macromolecul
synthesi
result
viru
infect
previous
shown
despit
rrna
degrad
cellular
protein
synthesi
remain
unaffect
infect
cell
h
pi
kulka
et
al
agreement
lack
effect
zvadfmk
rrna
degrad
requir
replic
viru
kulka
et
al
viru
replic
inhibit
treatment
compound
tabl
ribosom
rna
degrad
one
three
antivir
mechan
control
ifn
brought
activ
latent
ribonucleas
rnase
l
requir
ifn
treatment
cell
prior
viru
infect
fig
effect
ifn
rrna
degrad
dna
ladder
format
respons
infect
cell
either
pretreat
uml
h
h
pre
infect
treat
ifn
follow
viru
infect
h
post
h
pi
cytoplasm
nucleic
acid
isol
describ
section
analyz
agaros
gel
electrophoresi
b
treatment
rnase
assess
rna
dna
degrad
bracket
area
indic
posit
degrad
product
rrna
stark
et
al
barber
sen
contrast
rna
degrad
apoptosi
induc
requir
ifn
pretreat
cell
fig
investig
whether
ifn
involv
induc
rrna
degrad
apoptosi
cell
pretreat
uml
human
h
prior
exposur
viru
moi
pfucel
dna
rna
cytoplasm
infect
cell
analyz
h
pi
describ
section
fig
pretreat
ifn
modest
inhibitori
effect
rrna
degrad
apoptot
dna
degrad
particularli
low
moi
ifn
ad
cell
follow
h
viru
absorpt
period
neither
rna
degrad
dna
ladder
affect
ifn
treatment
fig
ifn
treatment
signific
growth
inhibitori
effect
low
moi
pfucel
infect
tabl
effect
viru
replic
clone
cell
h
treatment
period
data
shown
thu
involv
canon
ifn
regul
system
seem
unlik
rel
slow
replic
even
strain
might
allow
infect
cell
synthes
excret
ifn
howev
may
stimul
pathway
neighbor
uninfect
cell
caus
rna
degrad
address
question
two
differ
approach
first
level
ifn
oa
rnase
l
mrna
investig
rtpcr
determin
rna
induc
follow
viru
infect
fig
agreement
previou
report
hav
infect
induc
ifn
observ
signific
induct
ifn
messag
h
pi
viru
fig
panel
fig
rtpcr
amplif
select
cellular
viral
mrna
two
microgram
rna
isol
viru
infect
dsrna
treat
cell
revers
transcrib
volum
l
use
oligo
dt
primer
describ
section
five
microlit
rt
reaction
amplifi
cycl
sens
antisens
primer
oa
b
c
rnase
l
hav
genom
rna
e
describ
section
l
pcr
reaction
analyz
agaros
gel
electrophoresi
rna
uninfect
cell
ui
cell
transfect
absenc
dsrna
trfn
control
includ
rtpcr
analys
takahashi
et
al
success
demonstr
applic
rtpcr
detect
mrna
encod
oa
isoform
synthes
biolog
activ
form
use
primer
determin
mrna
either
form
fig
panel
b
form
data
shown
oa
induc
follow
viru
infect
treatment
cell
uml
induc
messag
form
panel
b
form
although
primer
pair
capabl
amplifi
mrna
mous
human
cell
data
shown
thu
cell
compet
mount
ifn
respons
induc
form
oa
rtpcr
experi
primer
rnase
l
hand
reveal
mrna
present
cell
constitut
increas
level
mrna
follow
viru
infect
panel
ascertain
clone
cell
activ
replicat
fig
stat
phosphoryl
respons
viru
infect
andor
treatment
cell
treat
h
prior
total
protein
extract
b
cell
mock
infect
infect
variou
time
infect
coxsacki
prior
protein
extract
c
cell
infect
pfucel
h
follow
addit
growth
medium
h
cell
treat
uml
growth
medium
nt
mean
treat
protein
extract
h
ifn
treatment
clone
cell
use
pi
western
blot
antibodi
unphosphoryl
stat
antistat
phosphoryl
stat
antistatp
actin
perform
describ
section
ing
viru
viral
genom
rna
amplifi
use
primer
direct
ntr
panel
e
result
clearli
show
presenc
undiminish
amount
viral
genom
clone
cell
sever
month
cultiv
indic
viru
acquir
base
repeat
present
genom
cp
strain
brack
et
al
zhang
et
al
second
determin
whether
stat
phosphoryl
occur
follow
viru
infect
phosphoryl
indic
activ
jakstat
pathway
prerequisit
transcript
induct
isg
ifn
review
see
stark
et
al
investig
signal
pathway
activ
follow
viral
infect
due
synthesi
low
level
ifn
phosphoryl
investig
immunoblot
analysi
fig
ifn
treat
cell
phosphoryl
observ
earli
min
posttreat
data
shown
peak
level
phosphoryl
detect
h
posttreat
panel
result
confirm
cell
capabl
respond
ifn
panel
howev
phosphoryl
detect
follow
infect
h
pi
panel
b
rrna
degrad
occur
previous
follow
stat
phosphoryl
h
pi
found
evid
activ
pathway
kulka
et
al
surprisingli
cell
infect
viru
h
show
diminish
phosphoryl
stat
treat
ifn
compar
uninfect
clone
cell
treat
ifn
panel
c
thu
cp
strain
hav
interfer
induct
ifn
dsrna
brack
et
al
also
interfer
ifn
signal
similarli
coxsackieviru
fastrepl
picornaviru
induc
similar
rna
degrad
cell
induc
phosphoryl
panel
b
data
clearli
suggest
exist
viru
induc
independ
rna
degrad
pathway
activ
infect
appar
absenc
ifn
induct
oa
studi
report
novel
pathway
rrna
degrad
cytopathogen
hepat
viru
infect
cell
observ
cleavag
speci
rrna
suggest
phenomenon
differ
cleavag
rrna
mous
hepat
viru
coronaviru
infect
cell
banerje
et
al
also
shown
viru
induc
rrna
cleavag
consequ
apoptosi
report
occur
result
perturb
cellular
macromolecular
synthesi
houg
previou
studi
shown
cleavag
rrna
also
accompani
reduct
level
cellular
mrna
viral
rna
significantli
affect
kulka
et
al
appear
specif
size
rrna
degrad
product
reminisc
ifn
regul
activ
rnase
l
activ
pathway
part
cellular
defens
viral
infect
requir
prior
exposur
cell
ifn
stark
et
al
barber
sen
rna
degrad
infect
howev
occur
without
prior
treatment
cell
ifn
conceiv
slowli
replic
viru
hav
could
induc
product
low
level
ifn
activ
pathway
surround
uninfect
cell
show
case
sinc
jakstat
pathway
activ
follow
viru
infect
even
though
mrna
margin
induc
clone
infect
cell
result
make
unlik
canon
depend
rna
degrad
pathway
activ
infect
also
show
rna
degrad
persist
infect
cell
despit
presenc
compar
level
viral
rna
antigen
protein
result
complement
result
brack
et
al
vallbracht
et
al
play
major
role
hav
infect
rnase
l
enzym
one
member
multicompon
system
rna
degrad
consist
ifn
oa
enzym
synthes
atp
presenc
dsrna
latent
endoribonucleas
rnase
l
rnase
l
gener
present
cell
may
function
situat
viru
infect
particularli
differenti
apoptosi
hormon
regul
chronic
fatigu
syndrom
certain
type
prostat
cancer
review
see
silverman
rnase
l
level
usual
unaffect
viru
infect
ifn
treatment
activ
presenc
proxim
activ
seri
uniqu
phosphodiest
link
oligoadenyl
acid
molecul
synthesi
depend
upon
induct
enzym
oa
activ
dsrna
activ
molecul
hepat
c
viru
core
protein
naganuma
et
al
show
oa
induc
infect
cell
despit
occurr
massiv
rna
degrad
also
show
failur
detect
oa
mrna
due
failur
rtpcr
protocol
genet
background
cell
sinc
treatment
cell
line
result
induct
form
oa
mrna
also
show
mrna
rnase
l
present
viru
infect
uninfect
cell
increas
level
mrna
follow
viru
infect
conclud
either
rnase
l
may
activ
factor
enzym
respons
rna
degrad
novel
rnase
specif
induc
activ
coxsackieviru
infect
cell
regard
ifn
treatment
shown
stimul
express
second
ribonucleas
identifi
nguyen
et
al
howev
enzym
exonucleas
neg
effect
ifn
treatment
rna
degrad
fig
argu
role
enzym
unlik
picornavirus
persist
infect
norm
rather
except
hav
least
vitro
tissu
cultur
cell
persist
infect
cc
strain
hav
suggest
result
ineffici
translat
initi
ire
whetter
et
al
funkhous
et
al
yi
et
al
recent
result
suggest
hav
ire
effici
ire
picornavirus
initi
translat
switch
translat
neg
strand
synthesi
ratelimit
step
hav
replic
kusov
also
suggest
slow
replic
even
replic
cp
strain
slow
compar
picornavirus
hav
result
regul
replic
viru
unknown
mechan
de
chastonay
siegl
discuss
slow
replic
hav
lack
function
proteas
often
overlook
picornavir
proteas
respons
promot
capindepend
translat
inactiv
possibl
translat
factor
ziegler
et
al
kerekatt
et
al
proteas
also
strong
induc
apoptosi
express
ectop
goldstaub
et
al
absenc
function
proteas
hav
viral
rna
compet
cellular
mrna
host
cell
translat
machineri
suggest
induct
rnase
activ
may
partial
compens
absenc
activ
proteas
reduc
competit
cellular
mrna
contribut
rapid
replic
phenotyp
possibl
cp
strain
hav
apoptosi
gener
thought
host
defens
respons
viru
infect
review
see
barber
prematur
induct
apoptosi
result
abort
viru
replic
howev
late
induct
apoptosi
might
favor
viru
allow
evad
host
immun
system
mani
virus
thu
evolv
mechan
delay
onset
apoptot
respons
roulston
et
al
similarli
induct
ifn
mediat
antivir
pathway
defens
respons
host
viru
infect
mani
virus
evolv
mechan
block
induct
ifn
mediat
antivir
pathway
review
see
barber
sen
therefor
surpris
two
major
ifn
mediat
antivir
pathway
name
l
pathway
dsrna
activ
pkr
pathway
also
mediat
apoptosi
among
picornavirus
hav
uniqu
slow
replic
permiss
cell
also
abil
initi
maintain
persist
infect
persist
infect
known
picornavirus
usual
requir
restrict
viru
replic
gene
express
use
inhibitor
cultur
cell
presum
host
ifn
regul
system
immun
system
intact
organ
agol
et
al
moreov
cp
strain
hav
kill
cell
apoptosi
cell
cultur
whole
organ
role
apoptosi
destruct
infect
cell
evad
host
immun
respons
uncertain
late
deplet
clearli
indic
hav
capabl
avoid
induct
necrosi
infect
cell
evad
host
immun
respons
conclus
present
evid
unlik
picornavirus
notabl
encephalomyocard
emc
viru
hav
rel
insensit
antivir
effect
ifn
furthermor
degrad
rrna
hav
infect
cell
occur
absenc
oa
key
enzym
regul
l
antivir
pathway
viru
abl
suppress
express
isg
includ
oa
interf
jakstat
signal
unknown
mechan
util
degrad
rna
mean
augment
replic
subsequ
induc
apoptosi
host
cell
